OVARIAN NEOPLASMS
Clinical trials for OVARIAN NEOPLASMS explained in plain language.
Never miss a new study
Get alerted when new OVARIAN NEOPLASMS trials appear
Sign up with your email to follow new studies for OVARIAN NEOPLASMS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could existing melanoma drugs work for other rare cancers? new trial aims to find out.
Disease control Not yet recruitingThis trial tests two approved drugs, dabrafenib and trametinib, in people with rare cancers that have a BRAF V600 mutation. The drugs are already used for melanoma and lung cancer. About 30 adults, children, and teens will take part. The goal is to see if the drugs shrink tumors …
Matched conditions: OVARIAN NEOPLASMS
Phase: PHASE2, PHASE3 • Sponsor: Cancer Research UK • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
New hope for tough ovarian cancer: phase 3 trial launches
Disease control Not yet recruitingThis phase 3 study tests a new drug, GSK5733584, against standard chemotherapy in about 450 adults with ovarian cancer that has stopped responding to platinum-based treatments. The goal is to see if the new drug can delay cancer growth and improve survival. Researchers will also …
Matched conditions: OVARIAN NEOPLASMS
Phase: PHASE3 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
Chemo spray trial offers hope for Hard-to-Treat ovarian cancer
Disease control Not yet recruitingThis early-phase study tests a method called PIPAC, which delivers chemotherapy as a pressurized spray directly into the abdomen. It is for women with ovarian cancer that has come back and is no longer responding to standard treatments. The goal is to find a safe dose and see if …
Matched conditions: OVARIAN NEOPLASMS
Phase: PHASE1, PHASE2 • Sponsor: Seoul National University Hospital • Aim: Disease control
Last updated May 15, 2026 11:53 UTC